LEO Pharma's Anzupgo® (delgocitinib) Cream Achieves Marketing Approval in Switzerland [Yahoo! Finance]
JAPAN TOBACCO UNSP/ADR (JAPAY)
NASDAQ:AMEX Investor Relations:
gungho.co.jp/en/ir
Company Research
Source: Yahoo! Finance
specifically indicated for the treatment of moderate to severe Chronic Hand Eczema (CHE) in adults who have had an inadequate response to topical corticosteroids, or for whom potent to very potent topical corticosteroids are not advisable. The approval will bring a new treatment option to approximately 4.7% of adults in Switzerland living with CHE, a condition with a high unmet need for which no specifically approved topical treatment was previously available. BALLERUP, Denmark, November 14, 2024 BUSINESS WIRE NOT FOR UK USE – NOT INTENDED FOR UK MEDIA LEO Pharma A/S, a global leader in medical dermatology, today announced that Swissmedic, Switzerland's national regulatory agency for approving and overseeing therapeutic products, has granted marketing approval for Anzupgo ® (delgocitinib) cream. The indication is for the treatment of moderate to severe Chronic Hand Eczema (CHE) in adults who have had an inadequate response to topical corticosteroids, or for whom potent to very p
Show less
Read more
Impact Snapshot
Event Time:
JAPAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAPAY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAPAY alerts
High impacting JAPAN TOBACCO UNSP/ADR news events
Weekly update
A roundup of the hottest topics
JAPAY
News
- Japan Tobacco Inc (JAPAF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- Proposed $32.5B tobacco deal not 'doomed to fail,' judge says in ruling [Yahoo! Finance Canada]Yahoo! Finance Canada
- Opinion: Take Big Tobacco's money and help people quit smoking [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Tobacco company opposes proposed $32.5B settlement with provinces, smokers: court doc [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Tobacco company opposes proposed $32.5-billion settlement with provinces, smokers: court document [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The